A Randomized Controlled Comparison of Azithromycin and Ofloxacin for Treatment of Multidrug-Resistant or Nalidixic Acid-Resistant Enteric Fever
- 1 July 2000
- journal article
- clinical trial
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 44 (7) , 1855-1859
- https://doi.org/10.1128/aac.44.7.1855-1859.2000
Abstract
To examine the efficacy and safety of short courses of azithromycin and ofloxacin for treating multidrug-resistant (MDR, i.e., resistant to chloramphenicol, ampicillin, and cotrimoxazole) and nalidixic acid-resistant enteric fever, azithromycin (1 g once daily for 5 days at 20 mg/kg/day) and ofloxacin (200 mg orally twice a day for 5 days at 8 mg/kg/day) were compared in an open randomized study in adults admitted to a hospital with uncomplicated enteric fever. A total of 88 blood culture-confirmed patients were enrolled in the study (86 with Salmonella enterica serovar Typhi and 2 with S. enterica serovar Paratyphi A). Of these, 44 received azithromycin and 44 ofloxacin. A total of 68 of 87 (78%) isolates were MDR serovar Typhi, and 46 of 87 (53%) were nalidixic acid resistant. The MIC 90 (range) of azithromycin was 8 (4 to 16) μg/ml for the isolates. The MIC 90 (range) of ofloxacin for the nalidixic acid-sensitive isolates was 0.03 (0.015 to 0.06) μg/ml and for the nalidixic acid-resistant isolates it was 0.5 (0.25 to 1.0) μg/ml. There was no significant difference in the overall clinical cure rate with ofloxacin and azithromycin (38 of 44 [86.4%] versus 42 of 44 [95.5%]; P = 0.27) or in the patients infected with nalidixic acid-resistant typhoid (17 of 21 [81.0%] versus 24 of 25 [96.0%]; P = 0.16). However, patients with nalidixic acid-resistant typhoid treated with ofloxacin had a longer fever clearance time compared with those treated with azithromycin (174 [60 to 264] versus 135 [72 to 186] h; P = 0.004) and had positive fecal cultures after the end of treatment (7 of 17 [41%] versus 0 of 19 [0%]; P = 0.002). Both antibiotics were well tolerated. A 5-day course of azithromycin was effective for the treatment of enteric fever due to MDR and nalidixic-acid-resistant serovar Typhi, whereas the ofloxacin regimen chosen was less satisfactory for these strains.Keywords
This publication has 26 references indexed in Scilit:
- A HIGHLY CEFTRIAXONE-RESISTANT SALMONELLA TYPHI IN BANGLADESHThe Pediatric Infectious Disease Journal, 1999
- Quinolone‐ResistantSalmonella typhiin Viet Nam: Molecular Basis of Resistance and Clinical Response to TreatmentClinical Infectious Diseases, 1997
- Short courses of ofloxacin for the treatment of enteric feverTransactions of the Royal Society of Tropical Medicine and Hygiene, 1997
- Multidrug-Resistant Salmonella typhi: A Worldwide EpidemicClinical Infectious Diseases, 1997
- The treatment of typhoid feverCurrent Opinion in Infectious Diseases, 1996
- Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in IndiaJournal of Antimicrobial Chemotherapy, 1996
- Efficacy of Azithromycin for Typhoid FeverClinical Infectious Diseases, 1995
- Azithromycin and typhoidThe Lancet, 1994
- Ciprofloxacin resistance in Salmonella paratyphi AJournal of Antimicrobial Chemotherapy, 1994
- Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in miceJournal of Antimicrobial Chemotherapy, 1993